The effects of growth hormone and sex steroid on lean body mass, fat mass, muscle strength, cardiovascular endurance and adverse events in healthy elderly women and men

被引:41
作者
Harman, SM
Blackman, MR
机构
[1] NIA, Intramural Res Program, NIH, Baltimore, MD 21224 USA
[2] Johns Hopkins Univ, Sch Med, Dept Internal Med, Div Endocrinol, Baltimore, MD USA
关键词
growth hormone; testosterone; oestrogen; sex hormones; elderly population; lean body mass; fat mass; adverse events;
D O I
10.1159/000071236
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Decreases in growth hormone (GH) and insulin-like growth factor I occur with age, in addition to oestrogen deficiency in women and a reduction in the levels of testosterone in men. These age-related hormonal changes may contribute to reductions in lean body mass, muscle strength and cardiac endurance, which can be partially reversed in elderly people with GH treatment, and testosterone supplements and oestrogen/progestin hormone replacement therapy in men and women, respectively. These treatments are, however, thought to have potentially serious adverse effects. We conducted a study to evaluate the separate and interactive effects of GH and sex steroids on body composition, muscle strength and cardiac endurance as well as the rate of adverse events in healthy elderly people. The results of the study showed that although there were beneficial effects with GH and sex steroid treatment, a high percentage of adverse effects occurred after 26 weeks of treatment, demonstrating a need for more research on the safety of hormonal therapy in the elderly population. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:121 / 124
页数:4
相关论文
共 16 条
[1]   GH replacement in 1034 growth hormone deficient hypopituitary adults:: demographic and clinical characteristics, dosing and safety [J].
Abs, R ;
Bengtsson, BÅ ;
Hernberg-Ståhl, E ;
Monson, JP ;
Tauber, JP ;
Wilton, P ;
Wüster, C .
CLINICAL ENDOCRINOLOGY, 1999, 50 (06) :703-713
[2]   The safety profile of GH replacement therapy in adults [J].
Chipman, JJ ;
Attanasio, AF ;
Birkett, MA ;
Bates, PC ;
Webb, S ;
Lamberts, SWJ .
CLINICAL ENDOCRINOLOGY, 1997, 46 (04) :473-481
[3]   CARPAL-TUNNEL SYNDROME AND GYNECOMASTIA DURING GROWTH-HORMONE TREATMENT OF ELDERLY MEN WITH LOW CIRCULATING IGF-I CONCENTRATIONS [J].
COHN, L ;
FELLER, AG ;
DRAPER, MW ;
RUDMAN, IW ;
RUDMAN, D .
CLINICAL ENDOCRINOLOGY, 1993, 39 (04) :417-425
[4]   HUMAN GROWTH-HORMONE AND HUMAN AGING [J].
CORPAS, E ;
HARMAN, SM ;
BLACKMAN, MR .
ENDOCRINE REVIEWS, 1993, 14 (01) :20-39
[5]   Longitudinal effects of aging on serum total and free testosterone levels in healthy men [J].
Harman, SM ;
Metter, EJ ;
Tobin, JD ;
Pearson, J ;
Blackman, MR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :724-731
[6]   EFFECTS OF RECOMBINANT HUMAN GROWTH-HORMONE ON METABOLIC INDEXES, BODY-COMPOSITION, AND BONE TURNOVER IN HEALTHY ELDERLY WOMEN [J].
HOLLOWAY, L ;
BUTTERFIELD, G ;
HINTZ, RL ;
GESUNDHEIT, N ;
MARCUS, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (02) :470-479
[7]   Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? [J].
Holly, JMP ;
Gunnell, DJ ;
Smith, GD .
JOURNAL OF ENDOCRINOLOGY, 1999, 162 (03) :321-330
[8]   Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency [J].
Johannsson, G ;
Rosen, T ;
Bosaeus, I ;
Sjostrom, L ;
Bengtsson, BA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (08) :2865-2873
[9]   Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults [J].
Johannsson, G ;
Grimby, G ;
Sunnerhagen, KS ;
Bengtsson, BK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (09) :2877-2884
[10]   EFFECTS OF SHORT-TERM ADMINISTRATION OF RECOMBINANT HUMAN GROWTH-HORMONE TO ELDERLY PEOPLE [J].
MARCUS, R ;
BUTTERFIELD, G ;
HOLLOWAY, L ;
GILLILAND, L ;
BAYLINK, DJ ;
HINTZ, RL ;
SHERMAN, BM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (02) :519-527